Portfolio company
BIONCaRT
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops stem cell therapies for knee cartilage regeneration to treat patients with orthopaedic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Altach Biomedical
This company develops biomimetic collagen scaffolds to regenerate damaged joint cartilage for patients with musculoskeletal injuries and osteoarthritis.
Hy2Care
This company develops injectable hydrogel implants that facilitate natural cartilage repair for patients with joint injuries to prevent osteoarthritis.
CartiHeal
This company develops aragonite-based implants for the regeneration of cartilage and bone in patients with traumatic or osteoarthritic joint defects.
OrthoPreserve
This company develops synthetic meniscus implants for patients with knee injuries to restore joint function and prevent the development of arthritis.
BONE THERAPEUTICS
This biotechnology company develops allogeneic cell therapy products for patients suffering from orthopaedic conditions and bone diseases.
GenuForm
This company develops artificial intelligence software to match donor grafts with recipients for knee cartilage transplantation surgery for healthcare providers and patients.
Altach
Altach manufactures biomimetic collagen scaffolds that regenerate damaged joint cartilage for orthopaedic surgeons and patients with musculoskeletal injuries.
EpiBone
This company grows personalized bone and cartilage grafts from a patient's own stem cells to treat individuals with skeletal defects.